BackSAB Biotherapeutics Overview

SAB Biotherapeutics Net Tangible Assets

SAB Biotherapeutics's net tangible assets is $230M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$227.25M

Peer average

Loading

SAB Biotherapeutics Net Tangible Assets History

Loading

SAB Biotherapeutics vs. peers: Net Tangible Assets Comparison

Loading

SAB Biotherapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

SAB Biotherapeutics (SABS) FAQ

As of the most recent data (March 2026), SABS shows a net tangible assets of $230M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SABS's net tangible assets is now $230M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether SAB Biotherapeutics is outperforming or lagging.

Tracking SABS's net tangible assets over time shows whether SAB Biotherapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $230M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has SAB Biotherapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $230M) with ownership activity and broader fundamentals.